- Home
- PLCE vs DXR Comparison
PLCE vs DXR Comparison
Compare PLCE & DXR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PLCE | DXR |
|---|---|---|
| Founded | 1969 | 1970 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Clothing/Shoe/Accessory Stores | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 72.5M | 59.0M |
| IPO Year | 1997 | 1995 |
Fundamental Metrics
Financial Performance| Metric | PLCE | DXR |
|---|---|---|
| Price | $2.54 | $10.85 |
| Analyst Decision | Hold | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $3.50 | N/A |
| AVG Volume (30 Days) | ★ 216.8K | 8.7K |
| Earning Date | 04-10-2026 | 02-27-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 11.48 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $1,446,345.00 |
| Revenue This Year | N/A | $44,935.22 |
| Revenue Next Year | $4.41 | $74.79 |
| P/E Ratio | ★ N/A | $33.83 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $2.04 | $8.56 |
| 52 Week High | $9.56 | $14.76 |
Technical Indicators
Market Signals| Indicator | PLCE | DXR |
|---|---|---|
| Relative Strength Index (RSI) | 48.04 | 56.73 |
| Support Level | $2.35 | $9.26 |
| Resistance Level | $2.88 | $10.99 |
| Average True Range (ATR) | 0.19 | 0.52 |
| MACD | 0.04 | 0.06 |
| Stochastic Oscillator | 44.64 | 82.80 |
Price Performance
Historical ComparisonAbout PLCE Children's Place Inc. (The)
Children's Place Inc operate an omni-channel children's specialty portfolio of brands in North America. It designs, contract to manufacture, and sell fashionable, high-quality apparel, accessories and footwear predominantly at value prices under proprietary The Children's Place, Place, Baby Place, Gymboree, Sugar & Jade, and PJ Place brand names. The Company classifies its business into two segments: The Children's Place U.S. and The Children's Place International.
About DXR Daxor Corporation
Daxor Corp is a medical instrumentation and biotechnology company focused on blood volume measurement. The company develops and markets the BVA-100 (Blood Volume Analyzer), the first diagnostic blood test cleared by the FDA offers unmatched, real-time, precise data via its rapid, hand-held, lab-based system.